GSK-843 free base · Synonyms: GSK'843
GSK-843 is a receptor-interacting protein kinase 3 inhibitor.
For research use only. Not for human or veterinary use.
GSK-843 structure
CAS No.: 1601496-05-2
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 25 mg | USD 465.00 | BP-02222-25mg | In stock | Get quote |
| 50 mg | USD 675.00 | BP-02222-50mg | In stock | Get quote |
| 100 mg | USD 975.00 | BP-02222-100mg | In stock | Get quote |
| 250 mg | USD 1,475.00 | BP-02222-250mg | In stock | Get quote |
Need another size or custom synthesis? Request a quote.
Description
GSK-843 (GSK'843) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 8.6 nM, and inhibits kinase activity with an IC50 of 6.5 nM. GSK-843 can be used for the research of inflammation .
Biological activity
GSK-843 (3-10 μM; 18 h) induces apoptosis GSK-843 (0.3-3 μM; 18 h) suppresses TNF-induced death and virus-induced cell necrosis
Identifiers
- SMILES
-
CC1=NN(C(=C1)C2=CN=C(C3=C2SC=C3C4=CC5=C(C=C4)SC=N5)N)C - InChIKey
-
BPKSNNJTKPIZKR-UHFFFAOYSA-N
Specifications
- MW (average)
- 377.4860
- Formula
- C19H15N5S2
- CAS No.
- 1601496-05-2
- Physical state
- Solid
- Color
- Light yellow to yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃ 2 years; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO
- In vitro
- DMSO : 50 mg/mL
Documents
References
Same target
Search RIP kinase- BP-01861A Nirogacestat dihydrobromide salt · >98%
- BP-01900A IACS-010759 HCl salt · >98%
- BP-01928 Bortezomib free base · >99%
- BP-01932 DEL-22379 free base · >98%
- BP-01934 APG-115 free base · >98%
- BP-01937 TAS4464 free base · >98%
- BP-01938 Clifutinib free base · >98%
- BP-01943 CDDO-3P-Im free base · >98%
Same research area
Search Inflammation/Immunology- BP-01931 BB-Cl-Amidine free base · >98%
- BP-01933 Bevurogant free base · >98%
- BP-01946 Ensifentrine free base · >98%
- BP-01947 Olutasidenib free base · >98%
- BP-02133A CRT0066101 dihydrochloride salt · >98%
- BP-02139 KIRA6 free base · >98%
- BP-02142 GSK805 free base · >98%
- BP-02148 NIK SMI1 free base · >98%